Marimed Stock Price, News & Analysis

MariMed (OTCQX: MRMD) has announced a new licensing agreement with The Stoned Moose to expand distribution of its Betty's Eddies™ full-spectrum fruit chews in Maine's $455 million cannabis market. The partnership will extend the brand's reach to include both adult-use and medical cannabis consumers, with medical sales representing over half of Maine's cannabis revenues in 2024.

Previously available only to adult-use consumers since 2022, Betty's Eddies will now be accessible to medical cannabis patients through The Stoned Moose's dual-license capabilities. The brand currently holds market leadership in edibles across Massachusetts, Maryland, and Delaware, targeting Maine's local consumer base and its 15 million annual tourists.

MariMed (OTCQX: MRMD) has announced a new licensing agreement with The Stoned Moose to expand distribution of its Betty's Eddies™ full-spectrum fruit chews in Maine's $455 million cannabis market. The partnership will extend the brand's reach to include both adult-use and medical cannabis consumers.

Previously available only to adult-use consumers since 2022, Betty's Eddies will now be accessible to medical cannabis patients, a significant market segment that represented over half of Maine's cannabis revenues in 2024. The brand currently leads market share for edibles in Massachusetts, Maryland, and Delaware.

MariMed Inc. (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, has scheduled its second quarter 2025 earnings release for August 6, 2025, after market close.

The company will host a conference call to discuss the financial results on August 7, 2025, at 8:00 a.m. EDT. Investors can access the webcast through MariMed's Investor Relations website, where a playback will also be available following the call.

MariMed (MRMD) has announced its readiness to participate in Delaware's expansion into adult-use cannabis sales, which will commence on August 1st, 2025. Through its Delaware business unit, First State Compassion (FSC), which has been the state's first licensed operator for 10 years, MariMed has already implemented improvements at its dispensaries in Wilmington and Lewes to handle increased customer traffic.

The company has begun scaling production at its cultivation and processing facilities in Wilmington and Milford to meet anticipated demand from both residents and the nearly 30 million annual tourists. MariMed's product portfolio in Delaware includes Betty's Eddies chews, currently the state's top-selling edible, along with FSC and Nature's Heritage flower brands, both ranking in the top five.

[ "First-mover advantage as Delaware's first licensed cannabis operator", "Strategic positioning with two dispensary locations in Wilmington and Lewes", "Market leadership with top-selling products including #1 edible brand", "Access to potential market of 30 million annual tourists", "Facilities already upgraded to handle increased customer traffic" ]

MariMed (MRMD) has launched MycroDose by Nature's Heritage, a new line of vegan wellness products combining cannabis with functional mushrooms in pill form. The product line features four distinct formulations available in Massachusetts dispensaries: Chill: For relaxation and stress relief, containing THC, CBD, Cordyceps, Lion's Mane, and Ashwagandha. G'Night: For improved sleep, featuring THC, CBN, CBD, Reishi, Lion's Mane, Chamomile, and Magnesium. Remedy: For inflammation reduction, including THC, CBD, CBC, Oyster mushroom, Ginger, Turmeric, and Piperine. Spark: For energy and focus, combining THCV, THC, Shiitake, Lion's Mane, and Ginseng. The products are currently available at MariMed's Panacea Wellness stores and select Massachusetts dispensaries.

MariMed Inc. (MRMD) reported its Q1 2025 financial results with revenue of $38.0 million, showing minimal growth from $37.9 million in Q1 2024. The company experienced declining profitability with GAAP net loss widening to $5.4 million from $1.3 million year-over-year. Gross margins decreased to 40% from 43%, while Adjusted EBITDA dropped to $2.6 million from $4.7 million. Despite challenges, wholesale sales now represent 44% of revenue mix, with the company's Betty's Eddies™ cannabis chews maintaining market leadership in multiple states. Notable developments include completing the First State Compassion Center acquisition in Delaware, launching Nature's Heritage™ products in Illinois, and introducing new Betty's Eddies™ caramel chews. The company appointed Ryan Crandall as Chief Commercial Officer to lead commercial strategy.

MariMed (CSE: MRMD, OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, has scheduled its first quarter 2025 earnings release for May 7, 2025 after market close.

The company will host a conference call to discuss the financial results on May 8, 2025 at 8:00 a.m. EDT. Investors can access the webcast through MariMed's Investor Relations website, where a playback will also be available after the call.

MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) has promoted Ryan Crandall to Chief Commercial Officer, effective immediately. In his new role, Crandall will oversee the company's commercial strategy, including Sales, Marketing, Product Development, and Retail Operations.

Crandall previously served as MariMed's Chief Revenue Officer since July 2022 and held positions as Chief Products Officer and SVP, Sales. He entered the cannabis industry in 2014 as co-creator of Betty's Eddies™, a cannabis-infused chews brand that was later acquired by MariMed. Before joining MariMed in 2018, he held executive positions in cybersecurity and software corporations, including RSA Security and EMC2.

MariMed Inc. (MRMD) has expanded its Betty's Eddies™ product line with the launch of Betty's Caramelt Away, a new THC and CBG-infused caramel chew. The product debuts on National Caramel Day (April 5) and is currently available in Massachusetts cannabis retailers, with planned expansion into other MariMed wholesale markets.

The new caramel chews are infused with full-spectrum hash and CBG, designed to create a mellow experience. Betty's Eddies currently holds the position of most popular edible brand in several core markets including Massachusetts, Maryland, and Delaware.

This addition joins Betty's existing product portfolio which includes:

• Bedtime Betty's for sleep
• Take It Easy Eddies for stress relief
• Go Betty Go for energy
• Ache Away Eddies for pain relief
• Smashin' Passion for sexual wellness
• Betty Good Times for recreational use